MPWT
GTBP icon

MassMutual Private Wealth & Trust’s GT Biopharma GTBP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47K Hold
3,000
– – ﹤0.01% 2081
2026
Q1 		$1.22K Buy
+3,000
New +$1.64K ﹤0.01% 2092

Other funds holding GTBP

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
KP
Kitching Partners Conshohocken, Pennsylvania $116M AUM 16.12% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $6.51B AUM 23.96% 1-Year Est. Return
TWP
Tempus Wealth Planning Irvine, California $511M AUM 28.39% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return

MassMutual Private Wealth & Trust's GTBP Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its GT Biopharma (GTBP) position steady in Q2 2026 at 3,000 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

MassMutual Private Wealth & Trust first reported a position in GTBP in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • MassMutual Private Wealth & Trust held 3,000 shares of GT Biopharma worth $1.47K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its GT Biopharma share count unchanged in Q2 2026.
  • GT Biopharma made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2081 holding.
  • MassMutual Private Wealth & Trust first reported a position in GT Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.